Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

CDK 4/6 inhibitors for older women with HR-positive breast cancer

Harpreet Singh - FDA, USA

CDK 4/6 inhibitors for older women with HR-positive breast cancer ( Harpreet Singh - FDA, USA )

Reducing risk of breast cancer recurrence and death with increased dose density

Prof Richard Gray - University of Oxford, Oxford, UK

Reducing risk of breast cancer recurrence and death with increased dose density ( Prof Richard Gray - University of Oxford, Oxford, UK )

Breast cancer therapy resistance mediated by FGFR amplification

Dr Luigi Formisano - Vanderbilt University Medical Center, Nashville, USA

Breast cancer therapy resistance mediated by FGFR amplification ( Dr Luigi Formisano - Vanderbilt University Medical Center, Nashville, USA )

The significance of CEACAM 5 in metastases of triple negative breast cancer

Emily Powell - MD Anderson Cancer Center, Houston, USA

The significance of CEACAM 5 in metastases of triple negative breast cancer ( Emily Powell - MD Anderson Cancer Center, Houston, USA )

Results of the MONALEESA 7 trial

Prof Debu Tripathy - MD Anderson Cancer Center, Houston, USA

Results of the MONALEESA 7 trial ( Prof Debu Tripathy - MD Anderson Cancer Center, Houston, USA )

The REACT trial: Celecoxib vs placebo for primary breast cancer

Prof Charles Coombes - Imperial College School of Medicine, London, UK

The REACT trial: Celecoxib vs placebo for primary breast cancer ( Prof Charles Coombes - Imperial College School of Medicine, London, UK )

Rationale and recruitment in the PARTNER trial

Dr Jean Abraham - University of Cambridge, Cambridge, UK

Rationale and recruitment in the PARTNER trial ( Dr Jean Abraham - University of Cambridge, Cambridge, UK )

The role of axiliary node dissection in modern breast cancer surgery

Dr Viviana Galimberti - European Institute of Oncology, Milan, Italy

The role of axiliary node dissection in modern breast cancer surgery ( Dr Viviana Galimberti - European Institute of Oncology, Milan, Italy )

Anastrozole duration for post-menopausal breast cancer patients after 5 years...

Dr Michael Gnant - Medizinischen Universität Wien, Vienna, Austria

Anastrozole duration for post-menopausal breast cancer patients after 5 years of endocrine therapy ( Dr Michael Gnant - Medizinischen Universität Wien, Vienna, Austria )

ER positive breast cancer: Screening for clinical variables to predict late...

Dr Ivana Sestak - Queen Mary University of London, London, UK

ER positive breast cancer: Screening for clinical variables to predict late distance disease recurrence ( Dr Ivana Sestak - Queen Mary University of London, London, UK )

Predicting late breast cancer recurrence with screening assays

Prof Jack Cuzick - Wolfson Institute of Prevention Medicine, London, UK

Predicting late breast cancer recurrence with screening assays ( Prof Jack Cuzick - Wolfson Institute of Prevention Medicine, London, UK )

The SOFT trial: Comparing adjuvant tamoxifen with ovarian function suppression...

Prof Gini Fleming - University of Chicago, Chicago, USA

The SOFT trial: Comparing adjuvant tamoxifen with ovarian function suppression via exemestane to tamoxifen alone ( Prof Gini Fleming - University of Chicago, Chicago, USA )

More from ecancer